EUVIMEDEUVIMED entdecken
Open Access

A Novel Scoring System for MYB RNA In Situ Hybridization Displays High Sensitivity and Specificity for Adenoid Cystic Carcinoma in a Clinical Setting

Mariel Bedell, Dale W Lewis, Raja R Seethala

Head and Neck Pathology · 2024

DOI: 10.1007/s12105-024-01656-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head and Neck Pathology, 2024. Verfasst von Mariel Bedell und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. bedellml@upmc.edu. Hauptthemen laut MEDLINE: Carcinoma, Adenoid Cystic, Proto-Oncogene Proteins c-myb, Sensitivity and Specificity, Biomarkers, Tumor. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Clinical and Translational Sciences Institute at the University of Pittsburgh.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: MYB RNA in situ hybridization (ISH) has emerged as a reliable and accessible marker to support adenoid cystic carcinoma (ACC) diagnosis, though still not well studied. Here, we report our results in a validation and prospective cohort to improve MYB RNA ISH diagnostic accuracy. METHODS: 79 cases (23 retrospective and 56 prospective) underwent MYB RNA ISH testing (44 ACC and 35 non-ACC). MYB RNA ISH results were initially interpreted based on previously established (original) scoring criteria. Weighted "i-scores", percent positive tumor cells, percent tumor cells with large signals (% LS), and staining pattern (abluminal, diffuse, focal non-patterned, or negative) were inputs for logistic regression models. Final model performance characteristics were compared with original scoring criteria and MYB::NFIB FISH results. RESULTS: An abluminal pattern was characteristic and exclusive to ACC. All i-scores, % LS, and percent positive were significantly higher in ACC. Original scoring criteria yielded a 95.5% sensitivity (Sn), 68.6% specificity (Sp), and 83.5% accuracy. MYB::NFIB FISH yielded a 42.9% sensitivity, 100% specificity, and 60% accuracy. Optimizing for performance, simplicity, and minimal collinearity, our final model was defined as: abluminal pattern and/or % LS > 16.5%, which resulted in a 93.2% Sn, 97.1% Sp, and 94.9% accuracy for ACC diagnosis. False negatives included an ACC with striking tubular eosinophilia and a MYBL1::NFIB translocated ACC. One false positive exclusive to the final model was a nasopharyngeal carcinoma with MYB amplification. CONCLUSIONS: MYB RNA ISH has a higher Sn than MYB::NFIB FISH while retaining high Sp. Our model provides improvements to specificity compared to original scoring criteria and highlight the importance of abluminal staining pattern and % LS. Nonetheless, alternate fusions remain key false negatives while rare non-ACC with other mechanisms of MYB activation may present as false positives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Adenoid CysticProto-Oncogene Proteins c-mybSensitivity and SpecificityBiomarkers, TumorHumansFemaleMiddle AgedMaleAgedAdultRetrospective StudiesIn Situ HybridizationProspective StudiesAged, 80 and overIn Situ Hybridization, FluorescenceYoung Adult

Stichwörter der Autor:innen

Myb geneAdenoid cystic carcinomaHybridizationIn situLogistic regressionQuantitative scoringSalivary gland neoplasmsmRNA

Substanzen

Proto-Oncogene Proteins c-mybMYB protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. bedellml@upmc.edu.
  • Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Förderung

  • Clinical and Translational Sciences Institute at the University of Pittsburgh

Zitieren

APA

Bedell, M., Lewis, D. W., & Seethala, R. R. (2024). A Novel Scoring System for MYB RNA In Situ Hybridization Displays High Sensitivity and Specificity for Adenoid Cystic Carcinoma in a Clinical Setting. Head and Neck Pathology. https://doi.org/10.1007/s12105-024-01656-z

Vancouver

Bedell M, Lewis DW, Seethala RR. A Novel Scoring System for MYB RNA In Situ Hybridization Displays High Sensitivity and Specificity for Adenoid Cystic Carcinoma in a Clinical Setting. Head and Neck Pathology. 2024. doi:10.1007/s12105-024-01656-z

BibTeX
@article{Bedell2024,
  author = {Bedell, Mariel and Lewis, Dale W and Seethala, Raja R},
  title = {A Novel Scoring System for MYB RNA In Situ Hybridization Displays High Sensitivity and Specificity for Adenoid Cystic Carcinoma in a Clinical Setting},
  journal = {Head and Neck Pathology},
  year = {2024},
  doi = {10.1007/s12105-024-01656-z}
}
Kostenlos starten →